 CAMBRIDGE, Mass., March 09, 2022 GLOBE NEWSWIRE -- Cullinan Oncology, Inc. Nasdaq: CGEM Cullinan, a biopharmaceutical company focused on developing a diversified pipeline of targeted therapies for cancer patients, today announced that it will be participating in the Barclays Healthcare Conference, being held in Miami, FL, March 15-17, 2022. 